Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookAssessment of the Pharmaceutical Sector in Ethiopia (FDRE-MOH, WHO; 2003; 61 pages)
View the documentACKNOWLEDGMENT
View the documentACRONYMS
View the documentEXECUTIVE SUMMARY
Open this folder and view contentsChapter I: Introduction
Open this folder and view contentsChapter II: Over all context of the study
close this folderChapter III: Findings and interpretations of the results
Open this folder and view contents1. Accessibility of key essential drugs
Open this folder and view contents2. Quality
close this folder3. Rational Drug Use
View the document3.1. Average number of drugs prescribed per encounter
View the document3.2. Percentage of antibiotic use
View the document3.3. Percentage of injection use
View the document3.4. Percentage of prescribed drugs included in the EDL
View the document3.5. Adequacy of Labeling of drugs
View the document3.6. Patient Knowledge
View the document3.7. Availability of STGs/EDLs in health facilities
close this folder3.8. Assessment of Treatment Practices
Open this folder and view contents3.8.1 Treatment of diarrhea (non-bloody, watery) in children
View the document3.8.2 Treatment of non-pneumonia ARTI
Open this folder and view contents3.8.3 Treatment of Mild/Moderate pneumonia
Open this folder and view contents4. House Hold Survey
Open this folder and view contentsChapter IV: Conclusion and Recommendation
View the documentAnnex I: National Regional States of Ethiopia
View the documentAnnex II: Six-tier and four-tier health care delivery systems
View the documentAnnex III: Distribution of Health Facilities and House Holds Surveyed
View the documentAnnex IV: LIST OF KEY ESSENTIAL DRUGS
View the documentAnnex V: Summary of National Indicators
 

3.8. Assessment of Treatment Practices

To measure the quality of care for common disease conditions with clear standard treatment guidelines, the utilization of STGs in health facilities was assessed by checking whether the chosen tracer diseases had been treated according to the treatment schedules recommended in the STGs.

For this purpose, three disease conditions, namely, diarrhoeal disease in children (watery, non-bloody), non-pneumonia Acute Respiratory Tract Infection (ARTI) and mild/moderate pneumonia were chosen. The recommended treatments are: ORS for watery, non-bloody diarrhea; non - use of antibiotic for non-pneumonia ARTI and use of any of the first line antibiotics for Mild/Moderate pneumonia (Procaine Penicillin, Amoxicillin or Cotrimoxazole). The records of 30 out-patients (10 patients for each disease) treated in the facility were selected randomly from the records of the day prior to the survey; when the number of cases was insufficient, by going back one day at a time until 10 cases were found for each disease condition. The records of the thirty patients were examined to determine if the treatments complied with their respective recommendations in the STGs. Then, the percentage of cases treated according to STGs was calculated at facility level, regional level and national level.

to previous sectionto next section

Please provide your feedback English  |  French